331 related articles for article (PubMed ID: 19267299)
21. In vivo immunomodulatory, cumulative skin irritation, sensitization and effect of d-limonene on permeation of 6-mercaptopurine through transdermal drug delivery.
Chandrashekar NS; Hiremath SR
Biol Pharm Bull; 2008 Apr; 31(4):656-61. PubMed ID: 18379058
[TBL] [Abstract][Full Text] [Related]
22. Transdermal permeability of N-acetyl-D-glucosamine.
Garner ST; Israel BJ; Achmed H; Capomacchia AC; Abney T; Azadi P
Pharm Dev Technol; 2007; 12(2):169-74. PubMed ID: 17510888
[TBL] [Abstract][Full Text] [Related]
23. Skin Permeation Enhancement in Aqueous Solution: Correlation With Equilibrium Enhancer Concentration and Octanol/Water Partition Coefficient.
Li SK; Chantasart D
J Pharm Sci; 2019 Jan; 108(1):350-357. PubMed ID: 30165068
[TBL] [Abstract][Full Text] [Related]
24. Impacts of chemical enhancers on skin permeation and deposition of terbinafine.
Erdal MS; Peköz AY; Aksu B; Araman A
Pharm Dev Technol; 2014 Aug; 19(5):565-70. PubMed ID: 23841559
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of percutaneous absorption of esculetin: effect of chemical enhancers.
del Rio Sancho S; Serna Jiménez CE; Calatayud Pascual MA; Balaguer Fernández C; Femenía Font A; Castillo García E; Merino V; López Castellano A
Planta Med; 2013 Jan; 79(2):131-6. PubMed ID: 23250808
[TBL] [Abstract][Full Text] [Related]
26. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
Pfister WR; Hsieh DS
Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
[TBL] [Abstract][Full Text] [Related]
27. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
[TBL] [Abstract][Full Text] [Related]
28. Chiral 4-
Chu T; Wang C; Wang J; Wang H; Geng D; Wu C; Zhao L; Zhao L
Drug Deliv; 2020 Dec; 27(1):723-735. PubMed ID: 32397753
[TBL] [Abstract][Full Text] [Related]
29. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
Pfister WR; Hsieh DS
Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
[TBL] [Abstract][Full Text] [Related]
30. Preparation and evaluation of 5, 9-dimethyl-2-cyclopropyl-2-decanol as a penetration enhancer for drugs through rat skin.
Khan GM; Hussain A; Hanif RM
Pak J Pharm Sci; 2011 Oct; 24(4):451-7. PubMed ID: 21959804
[TBL] [Abstract][Full Text] [Related]
31. Effect of fatty acids on the transdermal delivery of donepezil: in vitro and in vivo evaluation.
Choi J; Choi MK; Chong S; Chung SJ; Shim CK; Kim DD
Int J Pharm; 2012 Jan; 422(1-2):83-90. PubMed ID: 22037444
[TBL] [Abstract][Full Text] [Related]
32. Influence of ultrasound on the percutaneous absorption of ketorolac tromethamine in vitro across rat skin.
Tiwari SB; Pai RM; Udupa N
Drug Deliv; 2004; 11(1):47-51. PubMed ID: 15168791
[TBL] [Abstract][Full Text] [Related]
33. Development of antimigraine transdermal delivery systems of pizotifen malate.
Serna-Jiménez CE; del Rio-Sancho S; Calatayud-Pascual MA; Balaguer-Fernández C; Femenía-Font A; López-Castellano A; Merino V
Int J Pharm; 2015 Aug; 492(1-2):223-32. PubMed ID: 26196273
[TBL] [Abstract][Full Text] [Related]
34. Development of Tizanidine Drug-in-Adhesive Patch: Molecular Mechanism of Permeation Enhancer on Regulating Miscibility and Drug Release by Affecting the Status of Ion-Pair in Polymer Matrix.
Zhong T; Ruan J; Liu C; Quan P; Fang L
J Pharm Sci; 2020 Aug; 109(8):2501-2511. PubMed ID: 32387424
[TBL] [Abstract][Full Text] [Related]
35. Delivery of a classical antihypertensive agent through the skin by chemical enhancers and iontophoresis.
Nair A; Reddy C; Jacob S
Skin Res Technol; 2009 May; 15(2):187-94. PubMed ID: 19622129
[TBL] [Abstract][Full Text] [Related]
36. Transdermal delivery of ketorolac.
Amrish C; Kumar SP
Yakugaku Zasshi; 2009 Mar; 129(3):373-9. PubMed ID: 19252396
[TBL] [Abstract][Full Text] [Related]
37. Development and in vitro evaluation of pressure sensitive adhesive patch for the transdermal delivery of galantamine: Effect of penetration enhancers and crystallization inhibition.
Ameen D; Michniak-Kohn B
Eur J Pharm Biopharm; 2019 Jun; 139():262-271. PubMed ID: 30981946
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of Galantamine HBr Skin Permeation Using Sonophoresis and Limonene-Containing PEGylated Liposomes.
Rangsimawong W; Obata Y; Opanasopit P; Ngawhirunpat T; Takayama K
AAPS PharmSciTech; 2018 Apr; 19(3):1093-1104. PubMed ID: 29168128
[TBL] [Abstract][Full Text] [Related]
39. Transdermal delivery of glibenclamide and glipizide: in vitro permeation studies through mouse skin.
Mutalik S; Udupa N
Pharmazie; 2002 Dec; 57(12):838-41. PubMed ID: 12561248
[TBL] [Abstract][Full Text] [Related]
40. Ester prodrugs of morphine improve transdermal drug delivery: a mechanistic study.
Wang JJ; Sung KC; Huang JF; Yeh CH; Fang JY
J Pharm Pharmacol; 2007 Jul; 59(7):917-25. PubMed ID: 17637185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
